Family-Based Association Analysis Confirms the Role of the Chromosome 9q21.32 Locus in the Susceptibility of Diabetic Nephropathy

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Pezzolesi, Marcus G ^a,b   Jeong, Jackson ^a   Smiles, Adam M ^a   Skupien, Jan ^a,b   Mychaleckyj, Josyf C ^c   Rich, Stephen S ^c   Warram, James H ^a   Krolewski, Andrzej S ^a,b  

^a JOSLIN DIABETES CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; CHROMOSOME 9Q; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PLESIOMORPHY; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 9; DIABETIC NEPHROPATHIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84875504301     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060301     Document Type: Article

References (31)

1. Krolewski AS, Warram JH (1997) Clinical Features and Epidemiology of Diabetic Nephropathy. In: Pickup JC WG, editor. Textbook of Diabetes.2nd ed.Oxford: Blackwell Scientific Publications. pp. 53.51-53.13.
2. Parving HH, Mauer M, Ritz E (2004) Diabetic Nephropathy. In: BM B, editor. Brenner and Rector's The Kidney.7th ed. Philadelphia: Elsevier.pp. 1777-1818.
3. Seaquist ER, Goetz FC, Rich S, Barbosa J, (1989) Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161-1165.
4. Quinn M, Angelico MC, Warram JH, Krolewski AS, (1996) Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39: 940-945.
5. Faronato PP, Maioli M, Tonolo G, Brocco E, Noventa F, et al. (1997) Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. The Italian NIDDM Nephropathy Study Group. Diabetologia 40: 816-823.
6. Canani LH, Gerchman F, Gross JL, (1999) Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. Diabetes 48: 909-913.
7. Forsblom CM, Kanninen T, Lehtovirta M, Saloranta C, Groop LC, (1999) Heritability of albumin excretion rate in families of patients with Type II diabetes. Diabetologia 42: 1359-1366.
8. Fogarty DG, Hanna LS, Wantman M, Warram JH, Krolewski AS, et al. (2000) Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes 49: 1057-1063.
9. Fogarty DG, Rich SS, Hanna L, Warram JH, Krolewski AS, (2000) Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure. Kidney Int 57: 250-257.
10. Langefeld CD, Beck SR, Bowden DW, Rich SS, Wagenknecht LE, et al. (2004) Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. Am J Kidney Dis 43: 796-800.
11. Placha G, Canani LH, Warram JH, Krolewski AS, (2005) Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes. Adv Chronic Kidney Dis 12: 155-169.
12. Krolewski AS, Poznik GD, Placha G, Canani L, Dunn J, et al. (2006) A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int 69: 129-136.
13. Shimazaki A, Kawamura Y, Kanazawa A, Sekine A, Saito S, et al. (2005) Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy. Diabetes 54: 1171-1178.
14. Hanson RL, Craig DW, Millis MP, Yeatts KA, Kobes S, et al. (2007) Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes 56: 975-983.
15. Millis MP, Bowen D, Kingsley C, Watanabe RM, Wolford JK, (2007) Variants in the plasmacytoma variant translocation gene (PVT1) are associated with end-stage renal disease attributed to type 1 diabetes. Diabetes 56: 3027-3032.
16. Leak TS, Perlegas PS, Smith SG, Keene KL, Hicks PJ, et al. (2009) Variants in intron 13 of the ELMO1 gene are associated with diabetic nephropathy in African Americans. Ann Hum Genet 73: 152-159.
17. Pezzolesi MG, Katavetin P, Kure M, Poznik GD, Skupien J, et al. (2009) Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy. Diabetes 58: 2698-2702.
18. Pezzolesi MG, Poznik GD, Mychaleckyj JC, Paterson AD, Barati MT, et al. (2009) Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes 58: 1403-1410.
19. Hanson RL, Millis MP, Young NJ, Kobes S, Nelson RG, et al. (2010) ELMO1 variants and susceptibility to diabetic nephropathy in American Indians. Mol Genet Metab 101: 383-390.
20. Maeda S, Araki S, Babazono T, Toyoda M, Umezono T, et al. (2010) Replication study for the association between 4 loci identified by a genomewide association study on European American subjects with type 1 diabetes and susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes. Diabetes In Press.
21. Freedman BI, Langefeld CD, Lu L, Divers J, Comeau ME, et al. (2011) Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans. PLoS Genet 7: e1002150.
22. Pezzolesi MG, Poznik GD, Skupien J, Smiles AM, Mychaleckyj JC, et al. (2011) An intergenic region on chromosome 13q33.3 is associated with the susceptibility to kidney disease in type 1 and 2 diabetes. Kidney Int 80: 105-111.
23. Williams WW, Salem RM, McKnight AJ, Sandholm N, Forsblom C, et al. (2012) Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy. Diabetes 61: 2187-2194.
24. Klupa T, Warram JH, Antonellis A, Pezzolesi M, Nam M, et al. (2002) Determinants of the development of diabetes (maturity-onset diabetes of the young-3) in carriers of HNF-1alpha mutations: evidence for parent-of-origin effect. Diabetes Care 25: 2292-2301.
25. Warram JH, Gearin G, Laffel L, Krolewski AS, (1996) Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 7: 930-937.
26. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
27. Laird NM, Horvath S, Xu X, (2000) Implementing a unified approach to family-based tests of association. Genet Epidemiol 19Suppl 1: S36-42.
28. Sheehan S, Tsaih SW, King BL, Stanton C, Churchill GA, et al. (2007) Genetic analysis of albuminuria in a cross between C57BL/6J and DBA/2J mice. Am J Physiol Renal Physiol 293: F1649-1656.
29. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB, (2010) Rare variants create synthetic genome-wide associations. PLoS Biol 8: e1000294.
30. Martini S, Nair V, Patel SR, Eichinger F, Nelson RG, et al. (2013) From SNP to transcriptional mechanism: A model for FRMD3 in diabetic nephropathy. Diabetes In press.
31. Dolan V, Hensey C, Brady HR, (2003) Diabetic nephropathy: renal development gone awry? Pediatr Nephrol 18: 75-84.